What is the share price of Aster DM Healthcare Ltd (ASTERDM) today?
The share price of ASTERDM as on 6th March 2026 is ₹672.70. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Aster DM Healthcare Ltd (ASTERDM) share?
The past returns of Aster DM Healthcare Ltd (ASTERDM) share are- Past 1 week: 4.17%
- Past 1 month: 26.39%
- Past 3 months: 5.92%
- Past 6 months: 5.29%
- Past 1 year: 59.92%
- Past 3 years: 187.42%
- Past 5 years: 376.92%
What are the peers or stocks similar to Aster DM Healthcare Ltd (ASTERDM)?
The peers or stocks similar to Aster DM Healthcare Ltd (ASTERDM) include:What is the dividend yield % of Aster DM Healthcare Ltd (ASTERDM) share?
The current dividend yield of Aster DM Healthcare Ltd (ASTERDM) is 0.72.What is the market cap of Aster DM Healthcare Ltd (ASTERDM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aster DM Healthcare Ltd (ASTERDM) is ₹34774.32 Cr as of 6th March 2026.What is the 52 week high and low of Aster DM Healthcare Ltd (ASTERDM) share?
The 52-week high of Aster DM Healthcare Ltd (ASTERDM) is ₹732.20 and the 52-week low is ₹410.50.What is the PE and PB ratio of Aster DM Healthcare Ltd (ASTERDM) stock?
The P/E (price-to-earnings) ratio of Aster DM Healthcare Ltd (ASTERDM) is 6.47. The P/B (price-to-book) ratio is 9.52.Which sector does Aster DM Healthcare Ltd (ASTERDM) belong to?
Aster DM Healthcare Ltd (ASTERDM) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Aster DM Healthcare Ltd (ASTERDM) shares?
You can directly buy Aster DM Healthcare Ltd (ASTERDM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Aster DM Healthcare Ltd
ASTERDM Share Price
NSE₹672.702.63% (+17.25)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ASTERDM Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ASTERDM Performance & Key Metrics
ASTERDM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 106.35 | 9.52 | 0.72% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.59 | 5.77 | 0.58% |
100%
Analysts have suggested that investors can buy this stock
from 8 analysts
Price Upside
Earnings Growth
Rev. Growth
ASTERDM Company Profile
Aster DM Healthcare Limited is a healthcare service provider. The Company operates in various segments of the healthcare industry, which include hospitals, clinics and retail pharmacies
APOLLOHOSP
PE Ratio
76.81
76.81
1Y Return
23.12%
23.12%
Buy Reco %
86.21
86.21
MAXHEALTH
PE Ratio
94.24
94.24
1Y Return
4.21%
4.21%
Buy Reco %
81.82
81.82
FORTIS
PE Ratio
87.03
87.03
1Y Return
37.60%
37.60%
Buy Reco %
82.35
82.35
PE Ratio
45.12
45.12
1Y Return
11.15%
11.15%
Buy Reco %
77.78
77.78
MEDANTA
PE Ratio
61.94
61.94
1Y Return
11.40%
11.40%
Buy Reco %
73.33
73.33
ASTERDM Sentiment Analysis
ASTERDM Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ASTERDM Stock Summary · February 2026
Aster DM Healthcare is poised for significant growth following its merger with Quality Care, demonstrating a robust 15% revenue increase and a 22% rise in operating EBITDA. While operational challenges persist, particularly in the K&M cluster due to competitive pressures, the company is strategically enhancing its clinical capabilities and expanding its oncology services, which are projected to drive future revenue growth. Investments in new facilities and a focus on high-value care are complemented by disciplined cost management, ensuring operational efficiency. Despite facing material cost pressures and clinician attrition, the organization remains optimistic about its long-term prospects, bolstered by a strong liquidity position and a commitment to improving patient care across its expanding network.
ASTERDM Stock Growth Drivers
ASTERDM Stock Growth Drivers
8Strong Financial Performance
Aster DM Healthcare reported significant financial achievements, including a 15% year-on-year revenue growth in Q3
Successful Merger Progress
The merger with Quality Care India Limited has progressed significantly, receiving necessary approvals from the
ASTERDM Stock Challenges
ASTERDM Stock Challenges
5Margin Decline and Revenue Loss
The company has experienced a margin dip, with a notable decline from 22% to 20.2%
Concerns Over New Unit Performance
There are ongoing concerns regarding the performance of new Greenfield units, particularly in Trivandrum and
ASTERDM Forecast
ASTERDM Forecasts
Price
Revenue
Earnings
ASTERDM Share Price Forecast
ASTERDM Share Price Forecast
2026
Current
₹672.70
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹672.70
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
ASTERDM Company Revenue Forecast
ASTERDM Company Revenue Forecast
2025
Current
₹9.43
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹9.43
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
ASTERDM Stock EPS (Earnings Per Share) Forecast
ASTERDM Stock EPS (Earnings Per Share) Forecast
2025
Current
₹107.66
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹107.66
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ASTERDM
ASTERDM
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ASTERDM Income Statement
ASTERDM Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 933.21 | 1,107.73 | 977.67 | 6,121.79 | 1,121.68 | 1,082.80 | 1,031.62 | 1,111.05 | 1,225.46 | 1,213.73 | ||||||||||
Operating & Other expenses | 855.56 | 805.49 | 861.02 | 841.04 | 869.30 | 887.94 | 844.70 | 880.62 | 961.73 | 1,011.55 | ||||||||||
EBITDA | 77.65 | 302.24 | 116.65 | 5,280.75 | 252.38 | 194.86 | 186.92 | 230.43 | 263.73 | 202.18 | ||||||||||
| Depreciation/Amortization | 54.42 | 56.51 | 58.36 | 60.41 | 62.27 | 62.21 | 63.95 | 63.22 | 66.12 | 67.67 | ||||||||||
| PBIT | 23.23 | 245.73 | 58.29 | 5,220.34 | 190.11 | 132.65 | 122.97 | 167.21 | 197.61 | 134.51 | ||||||||||
| Interest & Other Items | 30.19 | 25.26 | 29.88 | 29.15 | 31.46 | 30.77 | 32.43 | 30.77 | 30.76 | 31.46 | ||||||||||
| PBT | -6.96 | 220.47 | 28.41 | 5,191.19 | 158.65 | 101.88 | 90.54 | 136.44 | 166.85 | 103.05 | ||||||||||
| Taxes & Other Items | 23.83 | 41.26 | 52.44 | 46.01 | 61.81 | 45.09 | 11.52 | 50.92 | 56.85 | 50.60 | ||||||||||
| Net Income | -30.79 | 179.21 | -24.03 | 5,145.18 | 96.84 | 56.79 | 79.02 | 85.52 | 110.00 | 52.45 | ||||||||||
| EPS | -0.62 | 3.60 | -0.48 | 103.34 | 1.94 | 1.14 | 1.59 | 1.67 | 2.13 | 1.02 |
ASTERDM Company Updates
FY 2026FY 2026
Investor Presentation
Feb 5PDF
Jan 30PDF
Nov 19PDF
+2 more
ASTERDM Stock Peers
ASTERDM Past Performance & Peer Comparison
ASTERDM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Aster DM Healthcare Ltd | 6.47 | 9.52 | 0.72% |
| Apollo Hospitals Enterprise Ltd | 76.81 | 10.01 | 0.16% |
| Max Healthcare Institute Ltd | 94.24 | 10.81 | 0.14% |
| Fortis Healthcare Ltd | 87.03 | 7.35 | 0.11% |
ASTERDM Stock Price Comparison
Compare ASTERDM with any stock or ETFCompare ASTERDM with any stock or ETF
ASTERDM
ASTERDM Holdings
ASTERDM Shareholdings
ASTERDM Promoter Holdings Trend
ASTERDM Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
Lower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
ASTERDM Institutional Holdings Trend
ASTERDM Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ASTERDM Shareholding Pattern
ASTERDM Shareholding Pattern
ASTERDM Shareholding History
ASTERDM Shareholding History
Foreign Institutions
Mutual Funds Invested in ASTERDM
Mutual Funds Invested in ASTERDM
No mutual funds holding trends are available
Top 5 Mutual Funds holding Aster DM Healthcare Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.8992% | Percentage of the fund’s portfolio invested in the stock 3.58% | Change in the portfolio weight of the stock over the last 3 months -0.61% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 5/88 (-2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.9160% | Percentage of the fund’s portfolio invested in the stock 3.97% | Change in the portfolio weight of the stock over the last 3 months -0.52% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 38/83 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.8423% | Percentage of the fund’s portfolio invested in the stock 2.28% | Change in the portfolio weight of the stock over the last 3 months -0.21% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 9/118 (-3) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ASTERDM stock
smallcases containing ASTERDM stock
Looks like this stock is not in any smallcase yet.
ASTERDM Events
ASTERDM Events
ASTERDM Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ASTERDM Dividend Trend
No dividend trend available
ASTERDM Upcoming Dividends
ASTERDM Upcoming Dividends
No upcoming dividends are available
ASTERDM Past Dividends
ASTERDM Past Dividends
Cash Dividend
Ex DateEx DateAug 28, 2025
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 28, 2025
Cash Dividend
Ex DateEx DateFeb 10, 2025
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Feb 10, 2025
Cash Dividend
Ex DateEx DateAug 22, 2024
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Aug 22, 2024
Cash Dividend
Ex DateEx DateApr 23, 2024
Special
Special | Div/Share: ₹118.00
Dividend/Share
₹118.00
Ex DateEx Date
Apr 23, 2024
ASTERDM Stock News & Opinions
ASTERDM Stock News & Opinions
Articles & Videos
Corporate
Aster DM Healthcare EGM scheduled
Aster DM Healthcare announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 10 March 2026.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Earnings
Aster DM Healthcare consolidated net profit declines 7.64% in the December 2025 quarter
Net profit of Aster DM Healthcare declined 7.64% to Rs 52.45 crore in the quarter ended December 2025 as against Rs 56.79 crore during the previous quarter ended December 2024. Sales rose 12.95% to Rs 1185.76 crore in the quarter ended December 2025 as against Rs 1049.81 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1185.761049.81 13 OPM %17.0817.68 - PBDT199.01187.81 6 PBT131.34125.60 5 NP52.4556.79 -8 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Aster DM Healthcare schedules board meeting
Aster DM Healthcare will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Aster DM Healthcare acquires further 11.94% stake in Prerana Hospitals
Aster DM Healthcare has completed the acquisition of 11.94% stake in Prerana Hospitals, thereby increasing the Company's shareholding from 87% to 98.92% while the balance 1.08% will be acquired by 31 December 2026. Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Aster DM Healthcare consolidated net profit rises 13.59% in the September 2025 quarter
Net profit of Aster DM Healthcare rose 13.59% to Rs 110.00 crore in the quarter ended September 2025 as against Rs 96.84 crore during the previous quarter ended September 2024. Sales rose 10.20% to Rs 1197.21 crore in the quarter ended September 2025 as against Rs 1086.44 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1197.211086.44 10 OPM %19.7019.99 - PBDT233.33220.92 6 PBT167.21158.65 5 NP110.0096.84 14 Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Aster DM Healthcare standalone net profit rises 16.44% in the September 2025 quarter
Net profit of Aster DM Healthcare rose 16.44% to Rs 104.61 crore in the quarter ended September 2025 as against Rs 89.84 crore during the previous quarter ended September 2024. Sales rose 12.76% to Rs 681.81 crore in the quarter ended September 2025 as against Rs 604.68 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales681.81604.68 13 OPM %21.9721.33 - PBDT171.91156.40 10 PBT132.79119.83 11 NP104.6189.84 16 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Aster DM Healthcare announces board meeting date
Aster DM Healthcare will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Aster DM Healthcare appoints Chief Information Officer & Chief Information Security Officer
Aster DM Healthcare has appointed Sudeep Dey as Chief Information Officer & Chief Information Security Officer, with effect from 01 August 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Aster DM Healthcare to hold AGM
Aster DM Healthcare announced that the 17th Annual General Meeting(AGM) of the company will be held on 4 September 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Aster DM Healthcare consolidated net profit declines 98.34% in the June 2025 quarter
Net profit of Aster DM Healthcare declined 98.34% to Rs 85.52 crore in the quarter ended June 2025 as against Rs 5145.18 crore during the previous quarter ended June 2024. Sales rose 7.59% to Rs 1077.87 crore in the quarter ended June 2025 as against Rs 1001.87 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1077.871001.87 8 OPM %18.7116.05 - PBDT204.05180.40 13 PBT140.83119.99 17 NP85.525145.18 -98 Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 1.66%, vs industry avg of 13.46%
Over the last 5 years, market share decreased from 20.84% to 11.47%
Over the last 5 years, net income has grown at a yearly rate of 81.03%, vs industry avg of 42.5%